Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Efficacy of Ferric Carboxymaltose (Ferinject®) in Anemic Patients Anticipating Pancreatoduodenectomy

NCT02628860 is registered in ClinicalTrials.gov with National Cancer Center, Korea as lead sponsor.

NCT NCT02628860
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT02628860 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Efficacy of Ferric Carboxymaltose (Ferinject®) in Anemic Patients Anticipating Pancreatoduodenectomy
Lead sponsor
National Cancer Center, Korea
Phase
Phase 2
Overall status
Completed
Start date
January 31, 2014
Completion date
April 27, 2020
Enrollment
40 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

anemia, pancreatic cancer